[Trabecular bone score in rheumatology : Are there benefits in comparison to bone densitometry alone?] / Trabecular Bone Score in der Rheumatologie : Gibt es einen Nutzen im Vergleich zur alleinigen Osteodensitometrie?
Z Rheumatol
; 82(8): 672-677, 2023 Oct.
Article
em De
| MEDLINE
| ID: mdl-37646845
ABSTRACT
Patients with inflammatory rheumatic diseases have an increased risk of fractures due to the inflammatory potential of the disease and also because of the treatment with glucocorticoids that is often necessary. According to the current guidelines of the Governing Body on Osteology (DVO), the fracture risk can be assessed using dual energy Xray absorptiometry and can also be supplemented by measuring the trabecular bone score (TBS). The assessment of the TBS offers additional advantages, for example in glucocorticoid-induced osteoporosis and in patients with osteoproliferative changes of the spine (spondylarthritis) and thus optimizes the fracture risk assessment in the rheumatological patient population.
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Guideline
/
Risk_factors_studies
Idioma:
De
Ano de publicação:
2023
Tipo de documento:
Article